Synovial Membrane–Derived Mesenchymal Stem Cells Supported by Platelet-Rich Plasma Can Repair Osteochondral Defects in a Rabbit Model

2013 ◽  
Vol 29 (6) ◽  
pp. 1034-1046 ◽  
Author(s):  
Jae-Chul Lee ◽  
Hyun Jin Min ◽  
Hee Jung Park ◽  
Sahnghoon Lee ◽  
Sang Cheol Seong ◽  
...  
2016 ◽  
Vol 15 (3) ◽  
Author(s):  
L.C. Hermeto ◽  
R. DeRossi ◽  
R.J. Oliveira ◽  
J.R. Pesarini ◽  
A.C.M.B. Antoniolli-Silva ◽  
...  

2006 ◽  
Vol 0 (0) ◽  
pp. 060706073730036
Author(s):  
Xinxin Shao ◽  
James C.H. Goh ◽  
Dietmar W. Hutmacher ◽  
Eng Hin Lee ◽  
Ge Zigang

Injury ◽  
2020 ◽  
Vol 51 (12) ◽  
pp. 2855-2865 ◽  
Author(s):  
Myrto Bami ◽  
Thomas Sarlikiotis ◽  
Mandy Milonaki ◽  
Myrofora Vikentiou ◽  
Evgenia Konsta ◽  
...  

2012 ◽  
Vol 18 (19-20) ◽  
pp. 2173-2186 ◽  
Author(s):  
Jae-Chul Lee ◽  
Sang Young Lee ◽  
Hyun Jin Min ◽  
Sun Ae Han ◽  
Jak Jang ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Johannes Zellner ◽  
Christian Dirk Taeger ◽  
Markus Schaffer ◽  
J. Camilo Roldan ◽  
Markus Loibl ◽  
...  

Meniscal lesions in the avascular zone are still a problem in traumatology. Tissue Engineering approaches with mesenchymal stem cells (MSCs) showed successful regeneration of meniscal defects in the avascular zone. However, in daily clinical practice, a single stage regenerative treatment would be preferable for meniscus injuries. In particular, clinically applicable bioactive substances or isolated growth factors like platelet-rich plasma (PRP) or bone morphogenic protein 7 (BMP7) are in the focus of interest. In this study, the effects of PRP and BMP7 on the regeneration of avascular meniscal defects were evaluated. In vitro analysis showed that PRP secretes multiple growth factors over a period of 8 days. BMP7 enhances the collagen II deposition in an aggregate culture model of MSCs. However applied to meniscal defects PRP or BMP7 in combination with a hyaluronan collagen composite matrix failed to significantly improve meniscus healing in the avascular zone in a rabbit model after 3 months. Further information of the repair mechanism at the defect site is needed to develop special release systems or carriers for the appropriate application of growth factors to support biological augmentation of meniscus regeneration.


Sign in / Sign up

Export Citation Format

Share Document